Back

A Territory-wide study of COVID-19 cases and clusters with unknown source in Hong Kong community: A clinical, epidemiological and phylogenomic investigation

Leung, K. S.-S.; Ng, T. T.-L.; Wu, A. K.-L.; Yau, M. C.-Y.; Lao, H.-Y.; Choi, M.-P.; Tam, K. K.-G.; Lee, L.-K.; Wong, B. K.-C.; Ho, A. Y.-M.; Yip, K.-T.; Lung, K.-C.; Liu, R. W.-T.; Tso, E. Y.-K.; Leung, W.-S.; Chan, M.-C.; Ng, Y.-Y.; Sin, K.-M.; Fung, K. S.-C.; Chau, S. K.-Y.; To, W.-K.; Que, T.-L.; Shum, D. H.-K.; Yip, S. P.; Yam, W.-C.; Siu, G. K. H.

2020-03-31 infectious diseases
10.1101/2020.03.30.20045740
Show abstract

Initial cases of COVID-19 reported in Hong Kong were mostly imported from China. However, most cases reported in February 2020 were locally-acquired infections, indicating local community transmissions. We extracted the demographic, clinical and epidemiological data from 50 COVID-19 patients, who accounted for 53.8% of the cases in Hong Kong by February 2020. Whole-genome sequencing of the SARS-CoV-2 were conducted to determine the phylogenetic relatedness and transmission dynamics. Only three (6.0%) patients required ICU admission. Phylogenetic analysis identified six transmission clusters. All locally-acquired cases harboured a common mutation Orf3a G251V and were clustered in two subclades in global phylogeny of SARS-CoV-2. The estimated time to the most recent common ancestor of local COVID-2019 outbreak was December 24, 2019 with an evolutionary rate of 3.04x10-3 substitutions per site per year. The reproduction number value was 1.84. Social distancing and vigilant epidemiological control are crucial to the containment of COVID-19 transmission. Article summary linesA combined epidemiological and phylogenetic analysis of early COVID-19 outbreak in Hong Kong revealed that a SARS-CoV-2 variant with ORF3a G251V mutation accounted for all locally acquired cases, and that asymptomatic carriers could be a huge public health risk for COVID-19 control.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Emerging Infectious Diseases
based on 84 papers
Top 0.1%
13.6%
2
The Lancet Infectious Diseases
based on 57 papers
Top 0.6%
6.6%
3
Scientific Reports
based on 701 papers
Top 27%
6.6%
4
PLOS ONE
based on 1737 papers
Top 71%
4.6%
5
International Journal of Infectious Diseases
based on 115 papers
Top 3%
3.0%
6
Journal of Medical Virology
based on 95 papers
Top 3%
3.0%
7
Nature Communications
based on 483 papers
Top 20%
3.0%
8
Emerging Microbes & Infections
based on 20 papers
Top 0.1%
3.0%
9
Frontiers in Public Health
based on 135 papers
Top 10%
2.9%
10
Eurosurveillance
based on 77 papers
Top 2%
2.9%
11
Viruses
based on 79 papers
Top 1%
2.5%
50% of probability mass above
12
Clinical Infectious Diseases
based on 219 papers
Top 11%
2.4%
13
eLife
based on 262 papers
Top 12%
2.4%
14
The Lancet Regional Health - Western Pacific
based on 14 papers
Top 0.1%
2.4%
15
Frontiers in Medicine
based on 99 papers
Top 8%
2.3%
16
The Journal of Infectious Diseases
based on 137 papers
Top 5%
1.9%
17
Science
based on 46 papers
Top 4%
1.6%
18
Journal of Infection
based on 64 papers
Top 4%
1.4%
19
Frontiers in Microbiology
based on 36 papers
Top 2%
1.4%
20
Infection, Genetics and Evolution
based on 14 papers
Top 1%
0.8%
21
Nature
based on 58 papers
Top 9%
0.8%
22
Journal of Travel Medicine
based on 17 papers
Top 1%
0.8%
23
Virus Evolution
based on 26 papers
Top 1%
0.7%
24
Cell
based on 28 papers
Top 3%
0.7%
25
BMC Infectious Diseases
based on 110 papers
Top 20%
0.7%
26
Microbial Genomics
based on 24 papers
Top 2%
0.7%
27
Frontiers in Physics
based on 11 papers
Top 2%
0.7%